Active transport of high-affinity choline and nicotine analogs into the central nervous system by the blood-brain barrier choline transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1268-1274

  Allen, David D ^a   Lockman, Paul R ^a   Roder, Karen E ^a   Dwoskin, Linda P ^b   Crooks, Peter A ^b  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CHOLINE DERIVATIVE; CHOLINE TRANSPORTER; CHOLINERGIC RECEPTOR; DOPAMINE; LOBELINE; N DECYLNICOTINIUM IODIDE; N METHYLNICOTINIUM IODIDE; N OCTYLCHOLINE; NICOTINE DERIVATIVE; PHENAZOPYRIDINE; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CALCULATION; CENTRAL NERVOUS SYSTEM; CIGARETTE SMOKING; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG BINDING; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG TISSUE LEVEL; DRUG UPTAKE; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SMOKING CESSATION;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CHOLINE; MALE; MEMBRANE TRANSPORT PROTEINS; NICOTINE; RATS; RATS, INBRED F344; TRITIUM;

EID: 0037369812     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.045856     Document Type: Article

References (32)

1. Allen DD, Matharu JRS, Crooks PA, and Smith QR (1996a) Comparison of the ligand binding sites of the blood-brain barrier, neuronal and erythrocyte choline transporters (Abstract). Soc Neurosci Abstr 22:771.
2. Allen DD, Matharu JRS, Crooks PA, and Smith QR (1996b) Characterization of the blood-brain barrier (BBB) choline (Ch) transporter. FASEB J 10:A691.
3. Allen DD, Oki J, and Smith QR (1997) An update in the in situ rat brain perfusion technique: simpler, faster, better. Pharm Res (NY) 14:337.
4. Allen DD and Smith QR (1999) Blood-brain barrier choline transport in the senescent rat. Neurosci Lett 277:198-202.
5. Allen DD and Smith QR (2001) Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique. J Neurochem 76:1032-1041.
6. Butt AM, Jones HC, and Abbott NJ (1990) Electrical resistance across the bloodbrain barrier in anaesthetized rats: a developmental study. J Physiol 429:47-62.
7. Cornford EM, Braun LD, and Oldendorf WH (1978) Carrier mediated blood-brain barrier transport of choline and certain analogs. J Neurochem 30:299-308.
8. 3H]dopamine release by pyridino N-substituted nicotine analogues: a new class of nicotinic antagonist. Drug Dev Res 36:91-102.
9. Diamond I (1971) Choline metabolism in brain. The role of choline transport and the effects of phenobarbital. Arch Neurol 24:333-339.
10. Dowdall MJ, Barrantes FJ, Stender W, and Jovin TM (1976) Inhibitory action of 1-pyrene butyrylcholine and related compounds on choline uptake by cholinergic nerve endings. J Neurochem 27:1253-1255.
11. Dwoskin LP and Crooks PA (2001) Competitive neuronal nicotinic receptor antagonists: a new direction for drug discovery. J Pharmacol Exp Ther 298:395-402.
12. Dwoskin LP, Xu R, Ayers JT, and Crooks PA (2000) Recent developments in neuronal nicotinic acetylcholine receptor antagonists. Exp Opin Ther Patents 10:1-21.
13. Gill JS, Shipley MJ, Tsementzis SA, Hornby R, Gill SK, Hitchcock ER, and Beevers DG (1989) Cigarette smoking. A risk factor for hemorrhagic and nonhemorrhagic stroke. Arch Int Med 149:2053-2057.
14. Goldenberg GJ and Begleiter A (1980) Membrane transport of alkylating agents. Pharmacol Ther 8:237-274.
15. Greig NH (1989) Drug delivery to the brain by blood-brain barrier circumvention and drug modification, in Implications of the Blood-Brain Barrier and Its manipulation (Neuwelt EA ed) pp 311-367, Plenum Press, New York.
16. Haustein KO (2000) Pharmacotherapy of nicotine dependence. Int J Clin Pharmacol Ther 38:273-290.
17. Lerner J (1989) Choline transport specificity in animal cells and tissues. Comp Biochem Physiol 93:1-9.
18. Lockman PR and Allen DD (2002) The transport of choline: a review. Drug Dev Ind Pharm 12:749-771.
19. Lockman PR, Roder KE, and Allen DD (2001) Inhibition of the rat blood-brain barrier choline transporter by manganese chloride. J Neurochem 79:588-594.
20. Metting TL, Burgio DE, Terry AV, Beach JW, McCurdy CR, and Allen DD (1998) Inhibition of brain choline uptake by isoarecolone and lobeline derivatives: implications for potential vector-mediated brain drug delivery. Neurosci Lett 258:25-28.
21. Pardridge WM (1997) Drug delivery to the brain. J Cereb Bl Fl Metab 17:713-731.
22. Pardridge WM (1998) CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70:1781-1792.
23. Simon JR, Mittag TW, and Kuhar JM (1975) Inhibition of synaptosomal uptake of choline by various choline analogs. Biochem Pharmacol 24:1139-1142.
24. Smith QR (1989) Quantitatian of blood-brain barrier permeability, in Implications of the Blood-Brain Barrier and Its Manipulation (Neuwelt EA ed) vol 1, pp 85-118, Plenum Press, New York.
25. Smith QR (1990) Advances in Neurology, in Alzheimer's Disease (Wurtman R ed) vol 51, pp 217-222, Raven Press, New York.
26. Smith QR (1993) Drug delivery to brain and the role of carrier-mediated transport. Adv Exp Med Biol 331:83-93.
27. Smith QR (1996) Brain perfusion systems for studies of drug uptake and metabolism in the central nervous system. Pharm Biotechnol 8:285-307.
28. Smith QR, Momma S, Aoyagi M, and Rapoport SI (1987) Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49:1651-1658.
29. Takasato Y, Rapoport SI, and Smith QR (1984) An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am J Physiol 247:484-493.
30. Vistica DT, Kenney S, Hursey ML, and Boyd MR (1994) Cellular uptake as a determinant of cytotoxicity of quaternized ellipticines to human brain tumor cells. Biochem Biophys Res Commun 200:1762-1768.
31. 3H]dopamine overflow from superfused rat striatal slices. J Pharmacol Exp Ther 301:1088-1096.
32. Xu R, Dwoskin LP, Grinevich VP, Sumithran SP, and Crooks PA (2002) Synthesis and evaluation of conformationally restricted pyridino N-alkylated nicotine analogs as nicotinic acetylcholine receptor antagonists. Drug Dev Res 55:173-186.